ForViva (LON:FVA – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Canaccord Genuity Group in a research report issued to clients and investors on Wednesday, September 30th, Digital Look reports. They currently have a GBX 190 price objective on the stock. Canaccord Genuity Group’s price objective suggests a potential upside of 29.25% from the stock’s previous close.
Separately, Shore Capital Group reissued a “hold” rating and set a GBX 135 price objective on shares of ForViva in a research note on Wednesday, September 30th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, ForViva currently has an average rating of “Moderate Buy” and an average target price of GBX 162.50.
Read Our Latest Stock Analysis on ForViva
ForViva Price Performance
Insiders Place Their Bets
In other ForViva news, insider Tim Jones bought 40,000 shares of the company’s stock in a transaction that occurred on Friday, July 17th. The shares were purchased at an average cost of GBX 138 per share, for a total transaction of £55,200. Insiders have purchased 90,000 shares of company stock valued at $12,380,000 in the last three months. 7.31% of the stock is owned by company insiders.
About ForViva
ForViva plc (LON: FVA) is a United Kingdom–based property company that operates in the residential and specialist housing sectors. The group’s activities are focused on ownership, management and leasing of housing assets that serve social, affordable and supported living needs. Its portfolio is oriented toward providing long‑term rental accommodation and specialist premises that accommodate people requiring additional care or support.
Services associated with ForViva’s property portfolio typically include day‑to‑day asset management, tenancy management, property maintenance and refurbishment, and collaboration with public sector bodies and third‑party care providers to deliver supported housing solutions.
Read More
- Five stocks we like better than ForViva
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
- Morgan Stanley Is Bullish on Apple—But With a Catch
Receive News & Ratings for ForViva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ForViva and related companies with MarketBeat.com's FREE daily email newsletter.
